Moreover, SHP2 expression was significantly and positively correlated with estrogen receptor expression (P = 0.026) (Table 2), and the high expression of SHP2 was associated with lymph node metastasis (P = 0.039). This evidence concerns the gene PTPN11 and metastatic malignant neoplasm in the lymph nodes.